Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
ESMO Open|October 2, 2018
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee surveySusana Banerjee, Urania Dafni, Tamara Allen, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
The Oncologist|March 29, 2025
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinomaJoel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, et al.
ESMO Open|October 2, 2018
Report on the status of women occupying leadership roles in oncologyEva Hofstädter-Thalmann, Urania Dafni, Tamara Allen, et al.
BMJ Oncology|January 31, 2025
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumoursAung Naing, Kyriakos P Papadopoulos, Michael J Pishvaian, et al.
Medical Image Analysis|March 12, 2025
SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancerAnna Kira Voronova, Athanasios Grigoriou, Kinga Bernatowicz, et al.
Nature Medicine|April 20, 2022
Delivering precision oncology to patients with cancerJoaquin Mateo, Lotte Steuten, Philippe Aftimos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced CancerRobert Jones, Ruth Plummer, Victor Moreno, et al.
British Journal of Cancer|May 4, 2021
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumoursJordi Rodon, Guillem Argilés, Roisin M Connolly, et al.
American Journal of Clinical Oncology|July 6, 2018
Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal CancerAntonio Cubillo, Rafael Álvarez-Gallego, Manuel Muñoz, et al.
Pageof 18